
Biora Therapeutics, INC.: management transactions · United States · SEC (Form 4)
SEC:biora-therapeutics-inc-7d3054USUS·SEC (Form 4)Mcap 777.3Bn€Technology
Browse the full insider trade history of Biora Therapeutics, INC., a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Technology sector, Biora Therapeutics, INC. has logged 8 insider filings. Market capitalisation: €777.3bn. The latest transaction was filed on 17 June 2022 — Attribution. Among the most active insiders: Kotzin Brian L.. All data is free.
Financial data
FY ended August 2025 · cache
Analyst consensus
41 analysts249.00 €Target 584.24 €1000.00 €
Income statement
Revenue37.38 Bn€
Gross profit14.87 Bn€40% margin
Net income8.54 Bn€41.5% margin
Valuation
PER (trailing)32.6x
PER (forward)6.7x
P/Book10.7x
Beta1.92
Balance sheet & cash
Market cap777.35 Bn€
Total debt15.28 Bn€
Free Cash Flow1.67 Bn€
Debt / Equity15%
Profitability & ownership
ROE39.8%
ROA20.1%
% insiders0.3%
% institutions81.1%
Last declaration on 17 June 2022